Cystic Fibrosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cystic Fibrosis stocks.

Cystic Fibrosis Stocks Recent News

Date Stock Title
May 31 CRBP Cannabis Stock Gainers And Losers From May 31, 2024
May 31 VRTX Analyst Expectations For Vertex Pharmaceuticals's Future
May 31 VRTX Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
May 30 INSM Insmed to Host Commercial Webinar on June 4, 2024
May 30 INSM Insmed announces pricing of $650M public offering
May 30 VRTX Vertex: Poised For Long-Term Growth Driven By Multiple Pipeline Catalysts
May 30 VRTX Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
May 30 VRTX Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
May 30 INSM Insmed Announces Pricing of $650 Million Public Offering of Common Stock
May 30 CRBP Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
May 30 VRTX Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
May 29 INSM Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
May 29 VRNA Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
May 29 PULM Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
May 29 SVRA Savara to Present at the Jefferies Global Healthcare Conference
May 29 PTCT PTC Therapeutics to Participate at Upcoming Investor Conference
May 29 INSM Insmed PT Raised to $67 at TD Cowen
May 29 INSM Insmed stocks soar as Phase III lung disease drug exceeds expectations
May 29 INSM Insmed intends to raise $500M via equity offering
May 28 INSM Insmed Announces Proposed $500 Million Public Offering of Common Stock
Cystic Fibrosis

Cystic fibrosis (CF) is a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Long-term issues include difficulty breathing and coughing up mucus as a result of frequent lung infections. Other signs and symptoms may include sinus infections, poor growth, fatty stool, clubbing of the fingers and toes, and infertility in most males. Different people may have different degrees of symptoms.CF is inherited in an autosomal recessive manner. It is caused by the presence of mutations in both copies of the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Those with a single working copy are carriers and otherwise mostly normal. CFTR is involved in production of sweat, digestive fluids, and mucus. When the CFTR is not functional, secretions which are usually thin instead become thick. The condition is diagnosed by a sweat test and genetic testing. Screening of infants at birth takes place in some areas of the world.There is no known cure for cystic fibrosis. Lung infections are treated with antibiotics which may be given intravenously, inhaled, or by mouth. Sometimes, the antibiotic azithromycin is used long term. Inhaled hypertonic saline and salbutamol may also be useful. Lung transplantation may be an option if lung function continues to worsen. Pancreatic enzyme replacement and fat-soluble vitamin supplementation are important, especially in the young. Airway clearance techniques such as chest physiotherapy have some short-term benefit, but long-term effects are unclear. The average life expectancy is between 42 and 50 years in the developed world. Lung problems are responsible for death in 80% of people with cystic fibrosis.CF is most common among people of Northern European ancestry and affects about one out of every 3,000 newborns. About one in 25 people is a carrier. It is least common in Africans and Asians. It was first recognized as a specific disease by Dorothy Andersen in 1938, with descriptions that fit the condition occurring at least as far back as 1595. The name "cystic fibrosis" refers to the characteristic fibrosis and cysts that form within the pancreas.

Browse All Tags